BeiGene, Ltd. (ONC)vsOSR Holdings Inc (OSRH)
ONC
BeiGene, Ltd.
$283.45
+2.81%
HEALTHCARE · Cap: $31.62B
OSRH
OSR Holdings Inc
$0.44
-3.11%
HEALTHCARE · Cap: $12.29M
Smart Verdict
WallStSmart Research — data-driven comparison
BeiGene, Ltd. generates -5903025% more annual revenue ($5.34B vs $-90,515). ONC leads profitability with a 5.4% profit margin vs 0.0%. ONC earns a higher WallStSmart Score of 42/100 (D).
ONC
Hold42
out of 100
Grade: D
OSRH
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-1983.5%
Fair Value
$16.86
Current Price
$283.45
$266.59 premium
Intrinsic value data unavailable for OSRH.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 32.8% year-over-year
Conservative balance sheet, low leverage
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
ROE of 7.5% — below average capital efficiency
5.4% margin — thin
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -8.9% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ONC
The strongest argument for ONC centers on Revenue Growth, Debt/Equity. Revenue growth of 32.8% demonstrates continued momentum.
Bull Case : OSRH
The strongest argument for OSRH centers on Price/Book.
Bear Case : ONC
The primary concerns for ONC are EPS Growth, Return on Equity, Profit Margin. A P/E of 111.0x leaves little room for execution misses.
Bear Case : OSRH
The primary concerns for OSRH are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
ONC profiles as a hypergrowth stock while OSRH is a value play — different risk/reward profiles.
OSRH carries more volatility with a beta of 1.55 — expect wider price swings.
ONC is growing revenue faster at 32.8% — sustainability is the question.
ONC generates stronger free cash flow (131M), providing more financial flexibility.
Bottom Line
ONC scores higher overall (42/100 vs 23/100) and 32.8% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BeiGene, Ltd.
HEALTHCARE · BIOTECHNOLOGY · USA
BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company is headquartered in Camana Bay, the Cayman Islands.
Visit Website →OSR Holdings Inc
HEALTHCARE · BIOTECHNOLOGY · USA
OSR Holdings Inc. is a leading provider of integrated managed services specializing in asset management and financial advisory solutions for institutional clients. By harnessing advanced technology and fostering strategic partnerships, the company not only enhances operational efficiency but also broadens its extensive service offerings. OSR Holdings places a strong emphasis on sustainable growth and client-centric value maximization, setting itself apart in a competitive landscape through its dedication to innovation and exceptional customer service. With a keen focus on emerging market opportunities, the firm maintains a rigorous risk management framework to ensure long-term stability and success.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?